Aberdeen Group
IOVA icon

Aberdeen Group’s Iovance Biotherapeutics IOVA Stock Holding History

Aberdeen Group’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$544K Sell
155,000
-604,522
-80% -$1.93M ﹤0.01% 874
2025
Q4 		$2.07M Buy
759,522
+152,312
+25% +$352K ﹤0.01% 775
2025
Q3 		$1.32M Buy
607,210
+90,921
+18% +$215K ﹤0.01% 817
2025
Q2 		$888K Buy
516,289
+384,489
+292% +$957K ﹤0.01% 837
2025
Q1 		$439K Hold
131,800
– – ﹤0.01% 879
2024
Q4 		$975K Hold
131,800
– – ﹤0.01% 826
2024
Q3 		$1.24M Hold
131,800
– – ﹤0.01% 797
2024
Q2 		$1.06M Buy
+131,800
New +$1.41M ﹤0.01% 818

Other funds holding IOVA

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
MFM
MHR Fund Management New York $1.37B AUM 68.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $2.17B AUM 0.03% 1-Year Est. Return